- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04129866
Mobile Interpretation Bias Modification Clinical Trial (M-IBM)
May 26, 2022 updated by: University of Southern Mississippi
The Mobile-Interpretation Bias Modification clinical trial aims to examine the efficacy of a brief mobile phone delivered interpretation bias modification to reduce anxiety sensitivity cognitive concerns and suicidal ideation in National Guard Personnel.
The investigators propose a randomized controlled trial testing the efficacy, acceptability, and usability of M-IBM with a sample of 114 National Guardsmen with current suicidal ideation and elevated anxiety sensitivity cognitive concerns.
Participants will complete assessments, receive assistance on installing M- IBM on their phone, complete an M-IBM intervention session, and complete post-intervention assessments.
Baseline measures of psychopathology, and usability/acceptability of M-IBM will be obtained during the initial session.
In addition, 1-month, and 3-month follow-ups would be scheduled to examine changes in psychopathology.
The investigators hypothesize that those randomized to M-IBM will experience reductions in anxiety sensitivity cognitive concerns, suicidal ideation.
In addition participants will find M-IBM acceptable and easy to use.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
114
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Mississippi
-
Hattiesburg, Mississippi, United States, 39406-0002
- University of Southern Mississippi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Elevated ASCC (>2) and include only Guard members who also have current SI (> 0) .
- Ownership of a smartphone
Exclusion Criteria:
- those determined by military or study personnel to be actively psychotic, manic, or imminently suicidal and in need of emergency services
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: M-IBM
M-IBM is based on a slightly modified version of the word sentence association paradigm focused on words and sentences related to common concerns among those with elevated anxiety sensitivity cognitive concerns (i.e., losing control of mental processes).
|
In this paradigm, an ambiguous word or two-word phrase related to ASCC is followed by a sentence that resolves the word-sentence meaning as threatening or benign.
For example, participants are presented with an ambiguous word or two-word phrase for 1 second.
On half the trials the combination of the word/phrase and sentence creates a benign meaning (as in the previous example).
On the other half of trials this combination creates an anxious-threat meaning Participants are required to judge the relatedness of the word/phrase and the sentence.
Participants are given feedback during training such that judging the anxious-threat combinations to be "unrelated" and the benign combinations as being "related" would produce a "correct" response.
In contrast, if participants produce an "incorrect" response they see "incorrect".
|
PLACEBO_COMPARATOR: Control IBM
Control-IBM is identical to M-IBM except that the sentence that follows the cue word is not related to an anxious-threat interpretation of the cue word.
|
Placebo IBM where sentences are not related to anxious threat meaning of cue word.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety Sensitivity Index-3 Cognitive Concerns Subscale
Time Frame: 30 minutes
|
Range 0 - 24, Higher Scores mean more pathology
|
30 minutes
|
Anxiety Sensitivity Index-3 Cognitive Concerns Subscale
Time Frame: 1 month post intervention
|
Range 0 - 24, Higher Scores mean more pathology
|
1 month post intervention
|
Anxiety Sensitivity Index-3 Cognitive Concerns Subscale
Time Frame: 3 months post intervention
|
Range 0 - 24, Higher Scores mean more pathology
|
3 months post intervention
|
The Self-Injurious Thoughts and Behaviors Interview
Time Frame: 1 month post intervention
|
1 month post intervention
|
|
The Self-Injurious Thoughts and Behaviors Interview
Time Frame: 3 months post intervention
|
3 months post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 15, 2019
Primary Completion (ANTICIPATED)
March 29, 2023
Study Completion (ANTICIPATED)
March 29, 2023
Study Registration Dates
First Submitted
October 10, 2019
First Submitted That Met QC Criteria
October 15, 2019
First Posted (ACTUAL)
October 17, 2019
Study Record Updates
Last Update Posted (ACTUAL)
May 27, 2022
Last Update Submitted That Met QC Criteria
May 26, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- W81XWH-16-2-0004 (Other Grant/Funding Number: Military Suicide Research Consortium)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicidal Ideation
-
University of WashingtonUnited States Department of Defense; Military Suicide Research ConsortiumCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation ActiveUnited States
-
The Catholic University of AmericaUniversity of Washington; VA Office of Research and DevelopmentCompletedSuicidal and Self-injurious Behavior | Suicidal Ideation Active
-
Emory UniversityGeorgia Institute of TechnologyCompletedSuicide, Suicidal IdeationUnited States
-
Henry M. Jackson Foundation for the Advancement...University of Pennsylvania; University of Michigan; Duke University; US Department... and other collaboratorsUnknownSuicide, Attempted | Suicidal Ideation ActiveUnited States
-
Technische Universität DresdenUnknownDepression | Suicidal Ideation/BehaviorGermany
-
International Islamic University, IslamabadRecruitingImpulsivity | Suicidal Ideation and BehaviorPakistan
-
VA Office of Research and DevelopmentCentral Texas Veterans Health Care SystemRecruitingHealth | Reintegration Difficulties | Suicidal Ideation and Behaviors | ConnectednessUnited States
-
Children's Hospital Medical Center, CincinnatiCompleted
-
Eisenhower Army Medical CenterAugusta University; The Geneva Foundation; Congressionally Directed Medical Research...CompletedSuicidal Ideation | Suicide | Suicidal Intention | Suicidal Impulses | Suicidal and Self-Injurious Behavior | Suicidal DepressionUnited States
-
Ohio State UniversityUniversity of Minnesota; Rutgers UniversityCompletedSuicidal Ideation | SuicidalUnited States
Clinical Trials on M-IBM
-
Tel Aviv UniversityCompleted
-
HighField Biopharmaceuticals CorporationRecruiting
-
Merck Sharp & Dohme LLCCompletedMeasles | Rubella | Mumps | VaricellaFrance, Italy
-
Fundació Institut de Recerca de l'Hospital de la...Sheba Medical Center; iMinds; Semmelweis University; AQuAS, Agència de Qualitat...CompletedSchizophreniaSpain, Hungary, Israel
-
Samueli Institute for Information BiologyWilliam Beaumont Army Medical Center; Palmer Center for Chiropractic Research... and other collaboratorsUnknown
-
Kreiskrankenhaus DormagenCompletedFeasibility of Measurement of a Neuromuscular Block at the m. TrapeziusGermany
-
CicloMed LLCCmed Clinical ServicesCompletedAdvanced Solid TumorsUnited States
-
University of the Incarnate Word59th Medical Wing; United States Naval Medical Center, San Diego; Madigan Army... and other collaboratorsCompletedPreterm Birth | Maternal | Infant, Low Birth Weight | Anxiety Fear | Prenatal DepressionUnited States
-
Tulane UniversityRecruitingDepression | AnxietyUnited States
-
National Institute of Allergy and Infectious Diseases...Merck Sharp & Dohme LLCCompletedHIV Infections | MeaslesUnited States, Puerto Rico